Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1856 2
1859 1
1958 1
1959 1
1961 1
1963 2
1964 2
1965 2
1966 2
1971 1
1972 1
1974 3
1975 2
1976 5
1977 5
1978 2
1979 4
1980 4
1981 1
1982 8
1983 9
1984 8
1985 6
1986 4
1987 9
1988 2
1989 7
1990 9
1991 5
1992 7
1993 17
1994 14
1995 18
1996 24
1997 17
1998 22
1999 34
2000 17
2001 25
2002 36
2003 33
2004 28
2005 32
2006 32
2007 39
2008 41
2009 28
2010 41
2011 44
2012 47
2013 45
2014 47
2015 54
2016 53
2017 57
2018 53
2019 40
2020 49
2021 49
2022 47
2023 47
2024 28

Text availability

Article attribute

Article type

Publication date

Search Results

1,155 results

Results by year

Filters applied: . Clear all
Page 1
Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA.
Abbosh C, Frankell AM, Harrison T, Kisistok J, Garnett A, Johnson L, Veeriah S, Moreau M, Chesh A, Chaunzwa TL, Weiss J, Schroeder MR, Ward S, Grigoriadis K, Shahpurwalla A, Litchfield K, Puttick C, Biswas D, Karasaki T, Black JRM, Martínez-Ruiz C, Bakir MA, Pich O, Watkins TBK, Lim EL, Huebner A, Moore DA, Godin-Heymann N, L'Hernault A, Bye H, Odell A, Roberts P, Gomes F, Patel AJ, Manzano E, Hiley CT, Carey N, Riley J, Cook DE, Hodgson D, Stetson D, Barrett JC, Kortlever RM, Evan GI, Hackshaw A, Daber RD, Shaw JA, Aerts HJWL, Licon A, Stahl J, Jamal-Hanjani M; TRACERx Consortium; Birkbak NJ, McGranahan N, Swanton C. Abbosh C, et al. Among authors: hodgson d. Nature. 2023 Apr;616(7957):553-562. doi: 10.1038/s41586-023-05776-4. Epub 2023 Apr 13. Nature. 2023. PMID: 37055640 Free PMC article.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
Castellino SM, Pei Q, Parsons SK, Hodgson D, McCarten K, Horton T, Cho S, Wu Y, Punnett A, Dave H, Henderson TO, Hoppe BS, Charpentier AM, Keller FG, Kelly KM. Castellino SM, et al. Among authors: hodgson d. N Engl J Med. 2022 Nov 3;387(18):1649-1660. doi: 10.1056/NEJMoa2206660. N Engl J Med. 2022. PMID: 36322844 Free PMC article. Clinical Trial.
The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group.
Constine LS, Yahalom J, Ng AK, Hodgson DC, Wirth A, Milgrom SA, Mikhaeel NG, Eich HT, Illidge T, Ricardi U, Dieckmann K, Moskowitz CH, Advani R, Mauch PM, Specht L, Hoppe RT. Constine LS, et al. Among authors: hodgson dc. Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1100-1118. doi: 10.1016/j.ijrobp.2018.01.011. Epub 2018 Jan 9. Int J Radiat Oncol Biol Phys. 2018. PMID: 29722655 Free article. Review.
Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial.
Clarke N, Wiechno P, Alekseev B, Sala N, Jones R, Kocak I, Chiuri VE, Jassem J, Fléchon A, Redfern C, Goessl C, Burgents J, Kozarski R, Hodgson D, Learoyd M, Saad F. Clarke N, et al. Among authors: hodgson d. Lancet Oncol. 2018 Jul;19(7):975-986. doi: 10.1016/S1470-2045(18)30365-6. Epub 2018 Jun 4. Lancet Oncol. 2018. PMID: 29880291 Clinical Trial.
Pediatric classical Hodgkin lymphoma.
Lo AC, Dieckmann K, Pelz T, Gallop-Evans E, Engenhart-Cabillic R, Vordermark D, Kelly KM, Schwartz CL, Constine LS, Roberts K, Hodgson D. Lo AC, et al. Among authors: hodgson d. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28562. doi: 10.1002/pbc.28562. Pediatr Blood Cancer. 2021. PMID: 33818890 Review.
Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial.
Ledermann J, Harter P, Gourley C, Friedlander M, Vergote I, Rustin G, Scott CL, Meier W, Shapira-Frommer R, Safra T, Matei D, Fielding A, Spencer S, Dougherty B, Orr M, Hodgson D, Barrett JC, Matulonis U. Ledermann J, et al. Among authors: hodgson d. Lancet Oncol. 2014 Jul;15(8):852-61. doi: 10.1016/S1470-2045(14)70228-1. Epub 2014 May 31. Lancet Oncol. 2014. PMID: 24882434 Clinical Trial.
Modelling the molecular mechanisms of aging.
Mc Auley MT, Guimera AM, Hodgson D, Mcdonald N, Mooney KM, Morgan AE, Proctor CJ. Mc Auley MT, et al. Among authors: hodgson d. Biosci Rep. 2017 Feb 23;37(1):BSR20160177. doi: 10.1042/BSR20160177. Print 2017 Feb 28. Biosci Rep. 2017. PMID: 28096317 Free PMC article. Review.
Reply to W.L. Lee et al.
Gupta S, Nathan PC, Hodgson D. Gupta S, et al. Among authors: hodgson d. J Clin Oncol. 2022 Sep 20;40(27):3226. doi: 10.1200/JCO.22.01054. Epub 2022 Jun 16. J Clin Oncol. 2022. PMID: 35709432 No abstract available.
1,155 results